標(biāo)題: Titlebook: Diagnostic and Therapeutic Advances in Pediatric Oncology; David O. Walterhouse,Susan L. Cohn Book 1997 Springer Science+Business Media Ne [打印本頁(yè)] 作者: 我在爭(zhēng)斗志 時(shí)間: 2025-3-21 16:29
書(shū)目名稱(chēng)Diagnostic and Therapeutic Advances in Pediatric Oncology影響因子(影響力)
書(shū)目名稱(chēng)Diagnostic and Therapeutic Advances in Pediatric Oncology影響因子(影響力)學(xué)科排名
書(shū)目名稱(chēng)Diagnostic and Therapeutic Advances in Pediatric Oncology網(wǎng)絡(luò)公開(kāi)度
書(shū)目名稱(chēng)Diagnostic and Therapeutic Advances in Pediatric Oncology網(wǎng)絡(luò)公開(kāi)度學(xué)科排名
書(shū)目名稱(chēng)Diagnostic and Therapeutic Advances in Pediatric Oncology被引頻次
書(shū)目名稱(chēng)Diagnostic and Therapeutic Advances in Pediatric Oncology被引頻次學(xué)科排名
書(shū)目名稱(chēng)Diagnostic and Therapeutic Advances in Pediatric Oncology年度引用
書(shū)目名稱(chēng)Diagnostic and Therapeutic Advances in Pediatric Oncology年度引用學(xué)科排名
書(shū)目名稱(chēng)Diagnostic and Therapeutic Advances in Pediatric Oncology讀者反饋
書(shū)目名稱(chēng)Diagnostic and Therapeutic Advances in Pediatric Oncology讀者反饋學(xué)科排名
作者: 有害 時(shí)間: 2025-3-21 22:03
Immunodeficiency states and related malignanciesof the problem drew the interest of experts in lymphoma morphology, it became clear that these were primarily B-lymphoid lymphoproliferations that ranged from benign, but aggressive, to frankly malignant diseases. Some of this understanding came as the result of improved classifications of lymphomas作者: Blazon 時(shí)間: 2025-3-22 02:32 作者: infarct 時(shí)間: 2025-3-22 08:01
Molecular basis of Wilms’ tumorumors. The generally favorable outcome for Wilms’ tumor patients can be partly attributed to medical advances, including refinement in surgical technique, the sensitivity of Wilms’ tumor to irradiation, and the availability of several active chemotherapeutic agents. The successful application of the作者: Baffle 時(shí)間: 2025-3-22 11:11
Neuroblastoma: solving a biologic puzzle. While virtually all patients with localized neuroblastoma can be cured by surgery alone, and most infants with disseminated disease are curable with chemotherapy, children with bone metastases usually have a fatal outcome [1–4]. Furthermore, in some patients the tumor undergoes spontaneous regress作者: 主動(dòng) 時(shí)間: 2025-3-22 13:55
Pediatric germ cell tumorsfferent degrees of malignancy and arising at different sites of origin. Only in the last decade has the biologic heterogeneity of germ cell tumors been recognized and addressed. Therapy tailored for the many biologically distinct subsets of germ cell tumors has yet to be defined. Because many catego作者: 主動(dòng) 時(shí)間: 2025-3-22 19:55 作者: Habituate 時(shí)間: 2025-3-22 22:02
The Ewing’s sarcoma family of tumors: Ewing’s sarcoma and peripheral primitive neuroectodermal tumorese small round cell tumors of bone came to be known as .. Soft tissue variants are called . Ewing’s sarcoma [2, 3] and the Askin tumor [4]. Bone and soft tissue tumors, which are quite similar to Ewing’s sarcoma under the light microscope but which have notable neural differentiation, have been den作者: STALL 時(shí)間: 2025-3-23 03:57 作者: 有助于 時(shí)間: 2025-3-23 06:23
Late effects of cancer therapy0% overall, with many subsets of patients demonstrating even worse outcome [1]. However, in the last three decades, treatment for malignancy in children has become far more effective. By the late 1980s, 60% to 70% of children with cancer (figure 1) were surviving their illness [2]. Although outcomes作者: 令人苦惱 時(shí)間: 2025-3-23 09:50 作者: Custodian 時(shí)間: 2025-3-23 13:50
Book 1997ary of how recent advances in cancer research are being applied to the care of children with solid tumors. The interface of cancer research with clinical practice in pediatric oncology has never been more intimate than today. While researchers are identifying oncogenes and tumor suppressor genes and作者: incredulity 時(shí)間: 2025-3-23 21:31 作者: alabaster 時(shí)間: 2025-3-24 01:33
Geotechnologies and the Environmentians are using knowledge of oncogenes and tumor suppressor genes for diagnosing cancer, for therapeutic decision making purposes, and for prognostic purposes. Clearly, the future will bring new therapies based on molecular genetic advances.作者: acrobat 時(shí)間: 2025-3-24 03:39 作者: 紋章 時(shí)間: 2025-3-24 09:02
Mathis Bode,Marco Davidovic,Heinz Pitschchildhood cancer [3]. This has created a new area of concern for pediatricians, oncologists, and internists. Dealing with the late effects of therapy, an unheard- of luxury in the 1960s, has now become a dilemma for patients, practitioners, and families of patients and must take a prominent position in the practice of pediatric oncology.作者: Complement 時(shí)間: 2025-3-24 12:28 作者: ABHOR 時(shí)間: 2025-3-24 16:23
Late effects of cancer therapychildhood cancer [3]. This has created a new area of concern for pediatricians, oncologists, and internists. Dealing with the late effects of therapy, an unheard- of luxury in the 1960s, has now become a dilemma for patients, practitioners, and families of patients and must take a prominent position in the practice of pediatric oncology.作者: 造反,叛亂 時(shí)間: 2025-3-24 22:18 作者: LIMIT 時(shí)間: 2025-3-24 23:31 作者: Ornament 時(shí)間: 2025-3-25 04:53 作者: 發(fā)生 時(shí)間: 2025-3-25 09:02
Geotechnologies and the Environmento clinical practice is beginning. While researchers are identifying oncogenes and tumor suppressor genes and studying their specific functions, clinicians are using knowledge of oncogenes and tumor suppressor genes for diagnosing cancer, for therapeutic decision making purposes, and for prognostic p作者: 平庸的人或物 時(shí)間: 2025-3-25 14:44 作者: 游行 時(shí)間: 2025-3-25 16:06
High-Performance Computing in Urban Modeling altered state so as to predispose to the development of cancer. Collectively, the application of these new gene discoveries will have a significant impact on public health in both pediatric and adult medical practices.作者: 吼叫 時(shí)間: 2025-3-25 21:10 作者: THROB 時(shí)間: 2025-3-26 01:33
Reservoir Simulation in the Cloud. While virtually all patients with localized neuroblastoma can be cured by surgery alone, and most infants with disseminated disease are curable with chemotherapy, children with bone metastases usually have a fatal outcome [1–4]. Furthermore, in some patients the tumor undergoes spontaneous regress作者: 滔滔不絕地講 時(shí)間: 2025-3-26 07:23
What Do HPC Applications Look Like?fferent degrees of malignancy and arising at different sites of origin. Only in the last decade has the biologic heterogeneity of germ cell tumors been recognized and addressed. Therapy tailored for the many biologically distinct subsets of germ cell tumors has yet to be defined. Because many catego作者: Palliation 時(shí)間: 2025-3-26 08:43
Markus Schr?der,Hans-Dieter Meyer of the efficacy of adjuvant chemotherapy has allowed 70% of patients with osteosarcoma to be cured of their disease. With the advances in our understanding of the biology of osteosarcoma, we are poised to improve this cure rate even further. This chapter highlights the latest information on the bio作者: 丑惡 時(shí)間: 2025-3-26 15:37 作者: 未成熟 時(shí)間: 2025-3-26 16:56
https://doi.org/10.1007/978-3-319-68394-2% of all cases of childhood cancer [1,2]. The traditional histologic classification scheme for rhabdomyosarcoma is primarily based on the degree of resemblance to normal fetal skeletal muscle prior to innervation [3]. These tumors are classified into two broad histiotypes, namely, embryonal and alve作者: 數(shù)量 時(shí)間: 2025-3-26 22:40
Mathis Bode,Marco Davidovic,Heinz Pitsch0% overall, with many subsets of patients demonstrating even worse outcome [1]. However, in the last three decades, treatment for malignancy in children has become far more effective. By the late 1980s, 60% to 70% of children with cancer (figure 1) were surviving their illness [2]. Although outcomes作者: Osmosis 時(shí)間: 2025-3-27 05:04 作者: Adrenal-Glands 時(shí)間: 2025-3-27 05:55 作者: 接合 時(shí)間: 2025-3-27 13:09
Markus Schr?der,Hans-Dieter Meyer of the efficacy of adjuvant chemotherapy has allowed 70% of patients with osteosarcoma to be cured of their disease. With the advances in our understanding of the biology of osteosarcoma, we are poised to improve this cure rate even further. This chapter highlights the latest information on the biology and treatment of osteosarcoma.作者: Arresting 時(shí)間: 2025-3-27 17:13 作者: groggy 時(shí)間: 2025-3-27 20:07 作者: FIR 時(shí)間: 2025-3-27 22:56
https://doi.org/10.1007/978-1-4615-5767-8cancer treatment; cell; childhood; heredity; tumor作者: entrance 時(shí)間: 2025-3-28 02:44
978-1-4613-7643-9Springer Science+Business Media New York 1997作者: 倔強(qiáng)不能 時(shí)間: 2025-3-28 07:48 作者: overweight 時(shí)間: 2025-3-28 13:08 作者: Inscrutable 時(shí)間: 2025-3-28 16:39
Diagnostic and Therapeutic Advances in Pediatric Oncology作者: 同謀 時(shí)間: 2025-3-28 22:28 作者: CHIP 時(shí)間: 2025-3-29 01:06 作者: 可憎 時(shí)間: 2025-3-29 06:10 作者: 網(wǎng)絡(luò)添麻煩 時(shí)間: 2025-3-29 08:58 作者: 北京人起源 時(shí)間: 2025-3-29 13:01 作者: peptic-ulcer 時(shí)間: 2025-3-29 17:16 作者: 無(wú)辜 時(shí)間: 2025-3-29 20:41
Reservoir Simulation in the Cloudedisposition, metastasis, treatment responsiveness, and prognosis. Continued study of these genetic abnormalities will hopefully lead to further insight into the molecular events associated with the malignant transformation of this heterogeneous tumor, and thereby provide clues for the development o